Home > Income Statement > KILITCH DRUGS (INDIA)

KILITCH DRUGS (INDIA)
Consolidated Net Profit

    Back to Income Statement
KILITCH DRUGS (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

KILITCH DRUGS (INDIA) Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹27 Cr₹15 Cr₹10 Cr₹7.37 Cr₹3.67 Cr

What is the latest Consolidated Net Profit of KILITCH DRUGS (INDIA) ?

The latest Consolidated Net Profit ratio of KILITCH DRUGS (INDIA) is ₹27 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹27 Cr
Mar2024₹15 Cr
Mar2023₹10 Cr
Mar2022₹7.37 Cr
Mar2021₹3.67 Cr

How is Consolidated Net Profit of KILITCH DRUGS (INDIA) Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹27 Cr
82.87
Mar2024 ₹15 Cr
39.75
Mar2023 ₹10 Cr
41.82
Mar2022 ₹7.37 Cr
100.68
Mar2021 ₹3.67 Cr -

Compare Consolidated Net Profit of peers of KILITCH DRUGS (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA) ₹617.4 Cr 6.6% -5.9% 6.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹408,847.0 Cr 7.1% -1.5% -6.2% Stock Analytics
DIVIS LABORATORIES ₹160,745.0 Cr 2.8% -2.8% 6% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,346.0 Cr 3.1% 4.2% 18.8% Stock Analytics
CIPLA ₹107,075.0 Cr 0.2% -12.5% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹103,507.0 Cr 2.2% -1.6% 0% Stock Analytics


KILITCH DRUGS (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
KILITCH DRUGS (INDIA)

6.6%

-5.9%

6.2%

SENSEX

1.5%

-2.3%

9.5%


You may also like the below Video Courses